Sanofi ( ($SNY) ) has provided an announcement. On February 13, 2025, Sanofi announced the discontinuation of the E.mbrace phase 3 study for its ...

The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over ...

Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by ...

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...

A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) ...

During an inspection, E. coli was found at 1,000 times the legal limit in Crosby, Texas, roughly 30 minutes northeast of Houston. Although the contaminated water isn't getting into the region's ...

Diarrheagenic E. coli (DEC) is a major global cause of diarrheal diseases, with certain strains showing alarming levels of antibiotic resistance.

Escherichia coli, commonly known as E. coli, is a versatile bacterium. While many strains are harmless and a natural part of our intestinal ...

Researchers have detailed the first E. coli O103 outbreak in England traced ... nine patients reported diarrhea; seven reported abdominal pain; five had bloody stools and nausea, and one reported ...

She's been seeing more and more people with the telltale signs of a Shigella infection, also known as shigellosis: diarrhea, stomach cramps and fever. Toronto has an outbreak of 11 confirmed ...

E. coli O157:H7 can cause severe illness, including dehydration, bloody diarrhea, and, in rare cases, kidney failure. Restaurants and consumers should discard or return any affected products ...